Обоснование. Недифференцированная эмбриональная саркома печени — редкая злокачественная опухоль мезенхимального происхождения, встречающаяся преимущественно в детском возрасте. Отсутствие специфических клинических, лучевых, лабораторных признаков приводит к поздней диагностике заболевания. Цель исследования: описание лучевой картины и определение характерных особенностей этой опухоли у детей по результатам анализа собственных наблюдений (n=6) и данных литературы. Методы. С 2008 по 2016 г. в НИИ детской онкологии были обследованы и получали лечение 6 пациентов с диагнозом недифференцированной эмбриональной саркомы печени (5 девочек и 1 мальчик) в возрасте от 4 мес до 11 лет (средний возраст составил 6,5 года). Диагноз подтвержден морфологически и иммуногистохимически. Результаты. Были установлены общие признаки недифференцированной эмбриональной саркомы, встречающиеся при всех лучевых методах исследования: образование имело большие размеры (в среднем 11,8 см), бугристые четкие контуры (6/6), было представлено солитарным узлом (6/6), не инфильтрировало сосуды печени (6/6). Не отмечалось нарушения капсулы печени и выхода опухоли за пределы органа (5/6). Также были выявлены отличия в данных, полученных при сонографии, магнитно-резонансной (МРТ) и компьютерной томографии (КТ). Так, при ультразвуковом исследовании в 5 случаях опухоль имела преимущественно солидное строение с наличием анэхогенных (кистозных) включений. При МРТ и КТ основная часть опухоли имела кистоподобную структуру с высоким содержанием жидкости. Заключение. Результаты данных комплексной лучевой диагностики позволяют заподозрить диагноз недифференцированной саркомы печени у детей благодаря многообразной картине структуры опухоли. Во всех случаях, подозрительных в отношении недифференцированной эмбриональной саркомы печени, морфологическое подтверждение до выработки плана лечения считаем обязательным.
30 April 2022 in Russian Journal of Pediatric Hematology and Oncology
The detection of an intraocular embryonic tumor – retinoblastoma (RB) – in children and its differential diagnosis with diseases mimicking RB is an important task of imaging. Considering that the clinical and radiological patterns of RB and the diseases mimicking it may be similar, and the choice of a treatment strategy is carried out without preliminary histological examination, the primary diagnosis is of decisive importance. A comprehensive diagnostic approach for suspected RB provides a timely choice of optimal treatment tactics and improves prognosis. The article presents the most demonstrative own observations. The literature review includes the modern possibilities of non-ionizing radiation diagnostics of RB and diseases mimicking as it.
17 January 2024 in Russian Journal of Pediatric Hematology and Oncology
Thyroid diseases in childhood occupy the second place after obesity in the structure of the general pathology of the endocrine system, eating disorders and metabolic disorders in children in the Russian Federation. Thyroid cancer in children makes up from 1.5 to 3 % of all malignant tumors, and from 8 to 22 % of malignant solid tumors of the head and neck, and the younger the child’s age, the more aggressive the disease proceeds.Familial forms of thyroid diseases may be associated with geographical features (living in iodine-deficient regions), but may also be part of hereditary syndromes, such as: multiple endocrine neoplasia syndromes (Sipple syndrome, Gorner syndrome, familial medullary thyroid cancer), DICER1 syndrome, Gardner syndrome, Cowden syndrome, McCune–Albright–Braitsev syndrome et al.This article describes several cases of thyroid pathology associated with DICER1 syndrome.
17 April 2023 in Russian Journal of Pediatric Hematology and Oncology
The aim of this work is to evaluate the informativity of the ultrasound (US) in detecting retinoblastoma (RB) and the local invasion of the tumor in children using modern multi-purpose ultrasound scanners.Materials and methods. This study included 108 patients (216 eyes) examined for suspected RB. RB was diagnosed in 91 patients, 60 children had unilateral tumor, 31 – bilateral tumor (122 eyes). In the remaining 17 children (20 eyes damaged), different non-tumor pathology of the eye was revealed. Among 122 eyes affected by RB, 51 were removed with subsequent histological examination. 27 eyes were removed before treatment, 24 – after chemotherapy.Results. In our study the informativity of ultrasound in detecting RB are: sensitivity – 98.4 %, specificity – 96.8 %, accuracy – 97.7 %. Sensitivity, specificity and accuracy in assessing tumor invasion to the anterior segment of the eye are 36.4 %, 95.0 % and 82.4 % respectively, to the vitreous body – 97.7 %, 100 % and 97.9 %, to the optic nerve – 54.5 %, 57.1 % and 54.9 %.Conclusion. US examination using linear transducers of 9–18 MHz is highly informative in detecting RB, however, some indicators of the effectiveness in assessing local invasion are not high enough, due to the technical possibilities of the method. One possible way to improve the informativity – to use deep sedation during US examination.
Treatment intensification of acute lymphoblastic leukemia in children with L-asparaginase (L-ASP) improves therapy effectiveness and shows high survival rates. The unique biological properties of this enzyme make it possible to suppress tumor blasts proliferation by reducing blood asparagine concentration. L-ASP use is limited by toxicity and hypersensitivity reactions observed in 75 % of cases. Although most complications during L-ASP therapy are mild/moderate and are manageable with adequate accompanying therapy, the development of severe side effects leads to forced withdrawal of L-ASP, which significantly reduces the likelihood of a favorable outcome in children with acute lymphoblastic leukemia. One of the most severe toxicity manifestations is the development of asparaginase-associated pancreatitis. It worsens the prognosis and may cause patients’ death. This article presents both current data about asparaginase-associated pancreatitis and treatment experience of this complication at the Research Institute of Pediatric Oncology and Hematology of the N. N. Blokhin National Research Center of Oncology.